The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro

International Immunopharmacology

Volumn 15, Issue 1, 2013, Pages 50-57

  Samara, Pinelopi ^a   Ioannou, Kyriaki ^a   Neagu, Monica ^b   Arnogiannaki, Niki ^c   Ardavanis, Alexandros ^c   Voelter, Wolfgang ^d   Tsitsilonis, Ourania ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^c SAINT SAVVAS HOSPITAL   (Greece)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antimicrobial functions; Breast cancer; Human neutrophils; Immunoreactive decapeptide; Prothymosin alpha

Indexed keywords

CYTOCHROME C; NITROBLUE TETRAZOLIUM; PROTHYMOSIN ALPHA; PROTHYMOSIN ALPHA(100-109); REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; NEUTROPHILS; PEPTIDES; PHAGOCYTOSIS; PROTEIN PRECURSORS; SUPEROXIDES; THYMOSIN; YOUNG ADULT;

EID: 84872334251     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.11.011     Document Type: Article

References (39)

1. A. Mantovani, M.A. Cassatella, C. Costantini, and S. Jaillon Neutrophils in the activation and regulation of innate and adaptive immunity Nat Rev Immunol 11 2011 519 531
2. J.P. Duignan, P.B. Collins, A.H. Johnson, and D. Bouchier-Hayes The association of impaired neutrophil chemotaxis with postoperative surgical sepsis Br J Surg 73 1986 238 240
3. M.A. Mendonça, F.Q. Cunha, E.F. Murta, and B.M. Tavares-Murta Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy Cancer Chemother Pharmacol 57 2006 663 670
4. R. Póka, S. Szûcs, R. Adány, and E. Szikszay Stage-related superoxide anion production of granulocytes of gynecologic cancer patients Eur J Obstet Gynecol Reprod Biol 89 2000 55 57
5. E. Jabłońska, W. Puzewska, M. Marcińczyk, Z. Grabowska, and J. Jabłoński iNOS expression and NO production by neutrophils in cancer patients Arch Immunol Ther Exp (Warsz) 53 2005 175 179
6. S. Trellakis, H. Farjah, K. Bruderek, C.A. Dumitru, T.K. Hoffmann, and S. Lang Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors Int J Immunopathol Pharmacol 24 2011 683 693
7. R.S. Stoika, M.D. Lutsik, M.L. Barska, A.A. Tsyrulnyk, and N.I. Kashchak In vitro studies of activation of phagocytic cells by bioactive peptides J Physiol Pharmacol 53 2002 675 688
8. G.H. Bae, H.Y. Lee, Y.S. Jung, J.W. Shim, S.D. Kim, and S.H. Baek Identification of novel peptides that stimulate human neutrophils Exp Mol Med 44 2012 130 137
9. G.P. Sandilands, J. McCrae, K. Hill, M. Perry, and D. Baxter Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils Immunology 119 2006 562 571
10. S. Culshaw, O.R. Millington, J.M. Brewer, and I.B. McInnes Murine neutrophils present Class II restricted antigen Immunol Lett 118 2008 49 54
11. F. Hayashi, T.K. Means, and A.D. Luster Toll-like receptors stimulate human neutrophil function Blood 102 2003 2660 2669
12. J. Fan, Y. Li, R.M. Levy, J.J. Fan, D.J. Hackam, and Y. Vodovotz Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling J Immunol 178 2007 6573 6580
13. M. Klink, M. Nowak, M. Kielbik, K. Bednarska, E. Blus, and M. Szpakowski The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro Cell Stress Chaperones 17 2012 661 674
14. A.A. Haritos, G.J. Goodall, and B.L. Horecker Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus Proc Natl Acad Sci U S A 81 1984 1008 1011
15. K. Ioannou, P. Samara, E. Livaniou, E. Derhovanessian, and O.E. Tsitsilonis Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy Cancer Immunol Immunother 61 2012 599 614
16. H. Heidecke, K. Eckert, K. Schulze-Forster, and H.R. Maurer Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients Int J Immunopharmacol 19 1997 413 420
17. M. Skopeliti, U. Kratzer, F. Altenberend, G. Panayotou, H. Kalbacher, and S. Stevanovic Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation Proteomics 7 2007 1814 1824
18. A. Mosoian, A. Teixeira, C.S. Burns, L.E. Sander, G.L. Gusella, and C. He Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction Proc Natl Acad Sci U S A 107 2010 10178 10183
19. M. Skopeliti, I.F. Voutsas, P. Klimentzou, M.L. Tsiatas, A. Beck, and A. Bamias The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients Cancer Immunol Immunother 55 2006 1247 1257
20. M. Skopeliti, V.A. Iconomidou, E. Derhovanessian, G. Pawelec, W. Voelter, and H. Kalbacher Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner Mol Immunol 46 2009 784 792
21. H. Oh, B. Siano, and S. Diamond Neutrophil isolation protocol J Vis Exp 17 2008 745
22. A. Panasiuk, J. Wysocka, E. Maciorkowska, B. Panasiuk, D. Prokopowicz, and J. Zak Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis World J Gastroenterol 11 2005 7661 7665
23. J.P. Sikora, D. Chlebna-Sokół, E. Andrzejewska, S. Chrul, E. Polakowska, and A. Wysocka Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation Scand J Immunol 68 2008 145 152
24. C.Y. Lee, M. Herant, and V. Heinrich Target-specific mechanics of phagocytosis: protrusive neutrophil response to zymosan differs from the uptake of antibody-tagged pathogens J Cell Sci 124 2011 1106 1114
25. M. Klink, K. Jastrzembska, M. Nowak, K. Bednarska, M. Szpakowski, and K. Szyllo Ovarian cancer cells modulate human blood neutrophils response to activation in vitro Scand J Immunol 68 2008 328 336
26. A. Szuster-Ciesielska, E. Hryciuk-Umer, A. Stepulak, K. Kupisz, and M. Kandefer-Szerszeń Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood Acta Oncol 43 2004 252 258
27. L.Y. Tsai, J.N. Tung, and T.Z. Liu Distinct differences in the induction of stimulus-mediated superoxide generation by polymorphonuclear neutrophils isolated from patients with different types of leukemia J Formos Med Assoc 107 2008 513 518
28. Y. Koga, A. Matsuzaki, A. Suminoe, H. Hattori, and T. Hara Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils Cancer Res 64 2004 1037 1043
29. C.N. Baxevanis, A.D. Gritzapis, O.E. Tsitsilonis, H.L. Katsoulas, and M. Papamichail HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes Int J Cancer 98 2002 864 872
30. N.R. Bertos, and M. Park Breast cancer - one term, many entities? J Clin Invest 121 2011 3789 3796
31. E.M. Reiche, S.O. Nunes, and H.K. Morimoto Stress, depression, the immune system, and cancer Lancet Oncol 5 2004 617 625
32. K.V. Rolston, G.P. Bodey, and A. Safdar Polymicrobial infection in patients with cancer: an underappreciated and underreported entity Clin Infect Dis 45 2007 228 233
33. A.N. Zagryazhskaya, S.C. Lindner, Z.V. Grishina, S.I. Galkina, D. Steinhilber, and G.F. Sud'ina Nitric oxide mediates distinct effects of various LPS chemotypes on phagocytosis and leukotriene synthesis in human neutrophils Int J Biochem Cell Biol 42 2010 921 931
34. J. El-Benna, P.M. Dang, and M.A. Gougerot-Pocidalo Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane Semin Immunopathol 30 2008 279 289
35. F. Sesti, O.E. Tsitsilonis, A. Kotsinas, and I.P. Trougakos Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis In Vivo 26 2012 395 402
36. A.M. Hicks, M.C. Willingham, W. Du, C.S. Pang, L.J. Old, and Z. Cui Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice Cancer Immun 6 2006 11
37. J. Pillay, B.P. Ramakers, V.M. Kamp, A.L. Loi, S.W. Lam, and F. Hietbrink Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia J Leukoc Biol 88 2010 211 220
38. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, and D.S. Weiss Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
39. Z. Granot, E. Henke, E.A. Comen, T.A. King, L. Norton, and R. Benezra Tumor entrained neutrophils inhibit seeding in the premetastatic lung Cancer Cell 20 2011 300 314